Trial Profile
Comparison between coagulations of RFA with sorafenib and standard RFA in patients with HCC.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Jul 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 07 Aug 2012 New trial record